| ProductNum | picture | CAS No. | Name and description | Formula | Quick order | 
|---|---|---|---|---|---|
| CL3522 | 
                         | 
                    86088-83-7 | 
                         Fibronectin 98+%  | 
                    — | |
| CL1844A | 
                         | 
                    253128-41-5 | 
                         Eribulin | B1939 | E7389 | ER-086526 98+%  | 
                    C40H59NO11 | |
| CL1869 | 
                         | 
                    908112-43-6 | 
                         SNX 2112 | PF-04928473 98+%  | 
                    C23H27F3N4O3 | |
| CL2903B | 
                         | 
                    142373-60-2 | 
                         Tirofiban hydrochloride | L700462 hydrochloride | MK383 hydrochloride) 98+%  | 
                    C22H37ClN2O5S | |
| CL2903A | 
                         | 
                    144494-65-5 | 
                         Tirofiban (Synonyms: L700462; MK383) 98+%  | 
                    C22H36N2O5S | |
| CL2903 | 
                         | 
                    150915-40-5 | 
                         Tirofiban Hydrochloride Monohydrate (Synonyms: Tirofiban HCl monohydrate; L700462 hydrochloride monohydrate; MK383 hydrochloride monohydrate) 98+%  | 
                    C22H39ClN2O6S | |
| CL2890 | 
                         | 
                    1228445-38-2 | 
                         Pyrintegrin | PTN | N-(Cyclopropylmethyl)-4-((4-(6-hydroxy-3,4-dihydroquinolin-1(2H)-yl)pyrimidin-2-yl)amino)benzenesulfonamide 98+%  | 
                    C23H25N5O3S | |
| CL2726 | 
                         | 
                    796073-69-3 | 
                         DM4 95+%  | 
                    C38H54ClN3O10S | |
| CL2644 | 
                         | 
                    1642288-47-8 | 
                         Mavacamten (MYK-461) 98+%  | 
                    C15H19N3O2 | |
| CL1348A | 
                         | 
                    1415246-68-2 | 
                         MMAF Hydrochloride;Monomethylauristatin F Hydrochloride 98+%  | 
                    C39H66ClN5O8 | |
| CL2467 | 
                         | 
                    1025967-78-5 | 
                         Lifitegrast; SAR 1118 98+%  | 
                    C29H24Cl2N2O7S | |
| CLA1358 | 
                         | 
                    1342290-43-0 | 
                         Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7) 95+%  | 
                    — | |
| CLA1352 | 
                         | 
                    1105038-73-0 | 
                         Abituzumab (Anti-Integrin aV / ITGAV / CD51) 95+%  | 
                    — | |
| CLA1265 | 
                         | 
                    1044758-60-2 | 
                         Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7) 95+%  | 
                    — | |
| CLA1226 | 
                         | 
                    339086-79-2 | 
                         Rovelizumab 95+%  | 
                    — | |
| CLA1211 | 
                         | 
                    211323-03-4 | 
                         Erlizumab (Synonyms: rhuMAb;Anti-Integrin b2 / ITGB2 / CD18) 95+%  | 
                    — | |
| CLA1196 | 
                         | 
                    558480-40-3 | 
                         Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) 95+%  | 
                    — | |
| CLA1185 | 
                         | 
                    892553-42-3 | 
                         Etaracizumab 95+%  | 
                    — | |
| CLA1118 | 
                         | 
                    143653-53-6 | 
                         Abciximab 95+%  | 
                    — | |
| CLA1108 | 
                         | 
                    159445-64-4 | 
                         Odulimomab 95+%  | 
                    — | |